Related references
Note: Only part of the references are listed.Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study
Ning Zhang et al.
BRACHYTHERAPY (2020)
Cervical Cancer, Version 3.2019
Wui-Jin Koh et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study
Nina Boje Kibsgaard Jensen et al.
RADIOTHERAPY AND ONCOLOGY (2018)
The Efficacy and Late Toxicities of Computed Tomography-based Brachytherapy with Intracavitary and Interstitial Technique in Advanced Cervical Cancer
Yun-Zhi Dang et al.
JOURNAL OF CANCER (2018)
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Marth et al.
ANNALS OF ONCOLOGY (2017)
Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer
Youngkyong Kim et al.
BRACHYTHERAPY (2017)
Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study
Renaud. Mazeron et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity
Supriya Chopra et al.
BRACHYTHERAPY (2015)
Curative Radiation Therapy for Locally Advanced Cervical Cancer: Brachytherapy Is NOT Optional
Kari Tanderup et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer
P. Georg et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Predictors of Toxicity After Image-guided High-dose-rate Interstitial Brachytherapy for Gynecologic Cancer
Larissa J. Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
DOSE-VOLUME HISTOGRAM PARAMETERS AND LATE SIDE EFFECTS IN MAGNETIC RESONANCE IMAGE-GUIDED ADAPTIVE CERVICAL CANCER BRACHYTHERAPY
Petra Georg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
CT-based 3D Dose-Volume Parameter of the Rectum and Late Rectal Complication in Patients with Cervical Cancer Treated with High-Dose-Rate Intracavitary Brachytherapy
Shingo Kato et al.
JOURNAL OF RADIATION RESEARCH (2010)
Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy
Woong Sub Koom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Systematic evaluation of MRI findings in different stages of treatment of cervical cancer:: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk
JCA Dimopoulos et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma
TH Kim et al.
CANCER (2005)
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
C Haie-Meder et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy:: Comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point
N Wachter-Gerstner et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Share Paper
